Clinical Trials Directory

Trials / Completed

CompletedNCT01231178

The Effect of an Alginate Based Beverage on Weight Loss

Alginate Fibers Effect on Body Weight and Risk Markers for Type 2 Diabetes and Cardiovascular Disease.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

The project aims to examine the efficacy of a 12-week intake of alginate based ready to drink supplement on development in body weight and body composition, and risk markers for type-2 diabetes and cardiovascular disease in obese subjects.

Detailed description

The study consists of a parallel RCT with 96 overweight/obese subjects enrolled into two treatment arms: placebo or active for 12 weeks. They will undergo examination at time points 0 and 12 weeks where a DXA scan will be performed to assess body composition and a fasting blood sample will be taken. At time points 0, 2, 4, 6, 8, 10 and 12 weeks their weight and waist circumference and number of test products not consumed will be recorded. In addition all subjects receive dietary counselling during the 12 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAlginate beverageThe dosage is 3x500ml daily
DIETARY_SUPPLEMENTControl beverageThe dosage is 3x500ml daily

Timeline

Start date
2010-02-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2010-11-01
Last updated
2010-11-01

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01231178. Inclusion in this directory is not an endorsement.